July 7, 2026 — SaniMed Science Group Founder and CEO Jim Wu, M.D., MBA, participated as an investor panelist in the TEN Capital Investor Education Series, providing feedback to four emerging companies across medical technology, precision diagnostics, consumer wellness, and health-focused food innovation.

BioTech (Shanghai) Chairman Jim Wu attended the 2025 Heartland Connect for Trade & Investment Conference, hosted by USHCA, engaging leaders from Mayo Clinic’s DMC and U.S. healthcare organizations. The event fostered dialogue on AI, healthcare access, and innovation, advancing U.S.–China collaboration and helping Chinese MedTech firms enter the American market.